Reports
Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global enzyme-linked immunosorbent assays (ELISAs) market is expected to grow at a CAGR of 3.0% during the period 2022-2027. The global market is expected to be driven by applications of enzyme-linked immunosorbent assays (ELISAs) in multiple settings, including rapid antibody screening tests for HIV, recognition of other viruses, fungi, bacteria, food allergens, autoimmune diseases, blood typing, presence of the pregnancy hormone hCG, forensic toxicology, laboratory and clinical research, and several other diagnostic settings. ELISAs are sensitive, precise, and inexpensive. These aspects are expected to drive the global market. North America, Europe and Asia are likely to be key markets.
Enzyme-linked immunosorbent assay (ELISA) is a labelled immunoassay accepted as the gold standard of immunoassays. The immunological test is very sensitive and is employed to detect and quantify substances, including antibodies, antigens, proteins, glycoproteins, and hormones. There are three common variations of enzyme-linked immunosorbent assays (ELISAs) - double antibody sandwich ELISA, indirect ELISA, and competitive ELISA; these have a broad variety of applications, including clinical, forensic and food research. Recognition of cancer biomarkers for early cancer detection is a task continually being researched and developed. Enzyme-linked immunosorbent assay (ELISA) based techniques are available and employed clinically for testing for early phases of cancer (including breast and ovarian cancer).
Enzyme-linked immunosorbent assay (ELISA) is also used to determine concentrations of illegal drugs, like cannabinoids, amphetamines, opiates, cocaine, benzodiazepines, and methadone, in urine samples. Further, the method may be used to monitor levels of pharmaceutical drug concentrations in individuals under treatment, for instance, antidrug antibodies in rheumatoid arthritis and inflammatory bowel disease. Enzyme-linked immunosorbent assay (ELISA) is also usually employed to test for the detection of hormone human chorionic gonadotrophin (hCG) in urine (which is present in higher amounts in pregnant women), thus enabling easy access and home testing capabilities.
Detection of platelet antibodies in serum is employed to recognize individuals suffering from disorders such as idiopathic thrombocytopenic purpura and systemic lupus erythematosus. These tests use alkaline phosphatase (enzyme), labelled with anti-human lgG. While being a less expensive and complicated method for detection of platelet antibodies, enzyme-linked immunosorbent assay (ELISA) is also reported to offer more than other generally employed tests, like the lymphocytotoxicity (LCT) and platelet immunofluorescence test (PIIFT). These aspects are expected to boost the global enzyme-linked immunosorbent assays (ELISAs) market.
In the food industry, enzyme-linked immunosorbent assay (ELISA) is popularly used to determine the presence of allergens for legally required ingredient labelling. The application benefits significantly from the sensitivity of ELISA and is able to detect levels of potential food allergen contaminants at concentrations on lower parts per million (ppm) scale. Further, it may be used to test for oils and other substances such as egg whites or milk, which other methods such as PCR are unable to detect.
The global enzyme-linked immunosorbent assays (ELISAs) market is expected to be stimulated by an important application – detection of viruses – which is especially useful for developing countries with high infection rates. The method can reach the most susceptible groups with on-site testing capabilities and prompt results, enabling opportunistic testing.
By test type, the market is segmented into:
By application, the market is divided into:
By region, the market is classified into:
The report presents a detailed analysis of the following key players in the global enzyme-linked immunosorbent assays (ELISAs) market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2021 |
Historical Period | 2017-2021 |
Forecast Period | 2022-2027 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Test Type |
|
Breakup by Application |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Enzyme-linked Immunosorbent Assays Market Analysis
8.1 Key Industry Highlights
8.2 Global Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market (2017-2021)
8.3 Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast (2022-2027)
8.4 Global Enzyme-linked Immunosorbent Assays (ELISAs) Market by Test Type
8.4.1 Sandwich ELISA
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Competitive ELISA
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Indirect ELISA
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 Multiple and Portable ELISA
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2017-2021)
8.4.4.3 Forecast Trend (2022-2027)
8.4.5 Others
8.5 Global Enzyme-linked Immunosorbent Assays (ELISAs) Market by Application
8.5.1 Cancer
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Protein Quantification
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Immunology
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Inflammation
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Infectious Diseases
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2017-2021)
8.5.5.3 Forecast Trend (2022-2027)
8.5.6 Other
8.6 Global Enzyme-linked Immunosorbent Assays (ELISAs) Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Thermo Fisher Scientific Inc.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Becton, Dickinson and Company
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 BioLegend, Inc.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Bio-Rad Laboratories, Inc.
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Enzo Life Sciences, Inc.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Enzyme-linked Immunosorbent Assays (ELISAs) Market: Key Industry Highlights, 2017 and 2021
2. Global Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Test Type (USD Million), 2017-2021
3. Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Test Type (USD Million), 2022-2027
4. Global Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Application (USD Million), 2017-2021
5. Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Application (USD Million), 2022-2027
6. Global Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Region (USD Million), 2017-2021
7. Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Region (USD Million), 2022-2027
8. North America Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2021
9. North America Enzyme-linked Immunosorbent Assays (ELISA) Market Forecast: Breakup by Country (USD Million), 2022-2027
10. Europe Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2021
11. Europe Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Asia Pacific Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2021
13. Asia Pacific Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Latin America Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2021
15. Latin America Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Middle East and Africa Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2021
17. Middle East and Africa Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Structure
The global enzyme-linked immunosorbent assays (ELISAs) market is projected to grow at a CAGR of 3.0% between 2022 and 2027.
The major drivers of the market include the increasing demand for cost-effective diagnostic tools, growing applications of ELISA in multiple settings, such as rapid antibody screening tests for HIV, rising need for frequent diagnostic testing, and increasing geriatric population.
The growing applications of ELISA in oncology and the rising incidence of infectious diseases and cancer are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Based on test type, the market is segmented into sandwich ELISA, competitive ELISA, indirect ELISA, multiple and portable ELISA, among others.
The significant applications of the market include cancer, protein quantification, immunology, inflammation, and infectious diseases, among others.
The major players in the industry are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, BioLegend, Inc., Bio-Rad Laboratories, Inc., and Enzo Life Sciences, Inc., among others.
The global enzyme-linked immunosorbent assays (ELISAs) market was driven by the rising incidence of infectious diseases and cancer in the historical period. Aided by the growing applications of ELISA in multiple settings, such as rapid antibody screening tests for HIV and rising need for frequent diagnostic testing, the market is expected to grow at a CAGR of 3.0% in the forecast period of 2022-2027.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on test type, the market is segmented into sandwich ELISA, competitive ELISA, indirect ELISA, multiple and portable ELISA, among others. The significant applications of the market are cancer, protein quantification, immunology, inflammation, and infectious diseases, among others. The major regional markets for enzyme-linked immunosorbent assays (ELISAs) are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The major players in the market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, BioLegend, Inc., Bio-Rad Laboratories, Inc., and Enzo Life Sciences, Inc., among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.